Cargando…
Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
BACKGROUND: There is uncertainty on the benefit of adjuvant chemotherapy in patients with stage II colorectal cancers. The aim of this study is to investigate the combined role of clinical, pathological and molecular parameters to identify those stage II patients who better benefit from adjuvant the...
Autores principales: | Donada, Marisa, Bonin, Serena, Barbazza, Renzo, Pettirosso, Daniel, Stanta, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599045/ https://www.ncbi.nlm.nih.gov/pubmed/23446022 http://dx.doi.org/10.1186/1471-230X-13-36 |
Ejemplares similares
-
Are Breast Cancer Molecular Classes Predictive of Survival in Patients with Long Follow-Up?
por: Pracella, Danae, et al.
Publicado: (2013) -
Is Human Papillomavirus Associated with Prostate Cancer Survival?
por: Pascale, Mariarosa, et al.
Publicado: (2013) -
Reduced expression of α-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients
por: Bonin, Serena, et al.
Publicado: (2018) -
PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement
por: Bonin, S., et al.
Publicado: (2019) -
The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
por: Pascale, Mariarosa, et al.
Publicado: (2016)